Agenus (AGEN) Operating Leases (2019 - 2026)
Agenus' (AGEN) quarterly Operating Leases came in at $9.8 million in Q1 2026, down 81.8% year-on-year from $54.0 million in Q1 2025, and down 2.78% quarter-over-quarter from $10.1 million in Q4 2025.
Agenus (AGEN) Operating Leases (2019 - 2026) Analysis & Trends
Agenus' Operating Leases history runs 8 years deep, the most recent figure standing at $9.8 million for Q1 2026.
- On a quarterly basis, Operating Leases fell 81.8% year-over-year to $9.8 million in Q1 2026; TTM through Mar 2026 was $9.8 million, a 81.8% decrease from a year earlier, with the FY2025 full-year figure at $10.1 million, down 81.47% from the prior year.
- Operating Leases fell to $9.8 million in Q1 2026 per AGEN's latest filing, from $10.1 million in the prior quarter.
- Across five years, Operating Leases topped out at $64.6 million in Q2 2022 and bottomed at $9.8 million in Q1 2026.
- The 5-year median for Operating Leases is $55.8 million (2024), against an average of $50.3 million.
- Across the five-year window, Operating Leases soared 85.51% in 2022 and sank 81.8% in 2026, its largest moves.
- Year by year, Operating Leases stood at $63.3 million in 2022, then declined by 1.29% to $62.5 million in 2023, then declined by 12.73% to $54.6 million in 2024, then sank by 81.47% to $10.1 million in 2025, then declined by 2.78% to $9.8 million in 2026.
- Per Business Quant, the three latest AGEN Operating Leases figures stand at $9.8 million (Q1 2026), $10.1 million (Q4 2025), and $10.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.83 Mn |
| Dec 31, 2025 | 10.11 Mn |
| Sep 30, 2025 | 10.38 Mn |
| Jun 30, 2025 | 53.39 Mn |
| Mar 31, 2025 | 53.98 Mn |
| Dec 31, 2024 | 54.55 Mn |
| Sep 30, 2024 | 55.16 Mn |
| Jun 30, 2024 | 55.79 Mn |
| Mar 31, 2024 | 61.76 Mn |
| Dec 31, 2023 | 62.51 Mn |
| Sep 30, 2023 | 63.17 Mn |
| Jun 30, 2023 | 62.25 Mn |
| Mar 31, 2023 | 62.86 Mn |
| Dec 31, 2022 | 63.33 Mn |
| Sep 30, 2022 | 63.82 Mn |
| Jun 30, 2022 | 64.57 Mn |
| Mar 31, 2022 | 47.42 Mn |
| Dec 31, 2021 | 42.11 Mn |
| Sep 30, 2021 | 38.90 Mn |
| Jun 30, 2021 | 34.81 Mn |